Last reviewed · How we verify

SIMETHICONE

FDA-approved approved ✓ Verified May 2026 Quality 5/100

SIMETHICONE is a drug. It is currently FDA-approved (first approved 1996).

Simethicone is an antifoaming agent used to treat various gastrointestinal conditions, including Irritable Bowel Syndrome, as seen in clinical trials. It is used as an on-demand medication, such as in the study "Assessment of On-demand MeteoSpasmyl Use Effectiveness in Irritable Bowel Syndrome".

At a glance

Generic nameSIMETHICONE
PhaseFDA-approved
First approval1996

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SIMETHICONE

What is SIMETHICONE?

SIMETHICONE is a pharmaceutical drug.

When was SIMETHICONE approved?

SIMETHICONE was first approved on 1996.

What development phase is SIMETHICONE in?

SIMETHICONE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing